In particular, SOD2 has been described as a tumor suppressor gene (Van Remmen et al., 2003) and its decreased expression level has been reported in a wide variety of diseases (Wang et al., 2016) (Hitchler et al., 2008), including hematological malignancies (Hurt et al., 2007). Here, SOD2 is linked to neoplasm.